Download the AMCP Engagement Framework at AMCP.org for Payers and Patient Organizations to find various resources, tools, examples, and instructions to guide payers and patient organizations in opening lines of communication to assist with incorporating the patient’s voice in decision-making processes.
In AMCP's Engagement Framework for Payers and Patient Organizations you can find various resources, tools, examples, and instructions to guide payers and patient organizations in opening lines of communication to assist with incorporating the patient’s voice in decision-making processes.
Download the AMCP Engagement Framework at AMCP.org for Payers and Patient Organizations to find various resources, tools, examples, and instructions to guide payers and patient organizations in opening lines of communication to assist with incorporating the patient’s voice in decision-making processes.
On April 4, 2023, the Centers for Medicare and Medicaid Services (CMS), published the Final
Contract Year (CY) 2024 Part D Bidding Instructions (Bidding Instructions).
The Health Equity Action Brief on Geographic Inequality highlights a concerning trend of widening geographic inequality over the past four decades and what managed care can do to address these potential policy biases.
AMCP's most recent Partnership Forum drew participants from a range of backgrounds and perspectives to discuss the value of collaboration between health plans/payers and patient advocacy organizations in managed care pharmacy decision-making. Senior VP of Professional and Government Affairs Jennifer Mathieu shares key insights and takeaways from the event.
AMCP webinar that reviewed a summary of discussions from the Market Insights Roundtable on ALS.
On Jan. 22, 2024, the Department of Health and Human Services (HHS) issued a
letter to Medicare plans, health insurance issuers, and State Medicaid and CHIP
programs (Letter) and a set of Frequently Asked Questions (FAQs) outlining how
plans and issuers can make sure they meet their contraception coverage
obligations.
In her latest blog post, AMCP CEO Susan Cantrell highlights her key takeaways from Dr. Freda Lewis-Hall's opening session at AMCP 2021.
Measures of medication adherence to noninsulin diabetes medications (NIDM), statins, and renin angiotensin system antagonists (RASA) have been continuously used in the star ratings program since 2012. Adherence to these treatments is undoubtedly important. However, the consistent use of these measures in the star ratings program over time has limitations.
In partnership with the Pharmacy Quality Alliance (PQA), AMCP is offering a Medication Use Quality continuing education program. The program provides advanced training on quality measurement and strategies to improve medication safety, adherence, and appropriate use. Participants can earn 15 accredited continuing education hours through the program. AMCP members receive a discount.
This JMCP article showcases the impact of a pharmacist-to-pharmacist transition of care model in reducing acute care utilization rates for heart failure at 30 and 90 days.